ELECTRA PRESCRIBING SERVICES LTD

Company Registration Number:
12111397 (England and Wales)

Unaudited abridged accounts for the year ended 31 July 2024

Period of accounts

Start date: 01 August 2023

End date: 31 July 2024

ELECTRA PRESCRIBING SERVICES LTD

Contents of the Financial Statements

for the Period Ended 31 July 2024

Balance sheet
Notes

ELECTRA PRESCRIBING SERVICES LTD

Balance sheet

As at 31 July 2024


Notes

2024

2023


£

£
Fixed assets
Intangible assets: 3 700,000 700,000
Tangible assets: 4 317,664 83,400
Total fixed assets: 1,017,664 783,400
Current assets
Stocks: 50,928 45,928
Debtors:   174,772 25,376
Cash at bank and in hand: 229,074 625,950
Total current assets: 454,774 697,254
Creditors: amounts falling due within one year:   (259,910) (303,953)
Net current assets (liabilities): 194,864 393,301
Total assets less current liabilities: 1,212,528 1,176,701
Creditors: amounts falling due after more than one year:   (333,328) (522,328)
Total net assets (liabilities): 879,200 654,373
Capital and reserves
Called up share capital: 236 236
Profit and loss account: 878,964 654,137
Shareholders funds: 879,200 654,373

The notes form part of these financial statements

ELECTRA PRESCRIBING SERVICES LTD

Balance sheet statements

For the year ending 31 July 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 28 April 2025
and signed on behalf of the board by:

Name: Dr Jarir Odeh Amarin
Status: Director

The notes form part of these financial statements

ELECTRA PRESCRIBING SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

ELECTRA PRESCRIBING SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

2. Employees

2024 2023
Average number of employees during the period 8 8

ELECTRA PRESCRIBING SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

3. Intangible Assets

Total
Cost £
At 01 August 2023 700,000
At 31 July 2024 700,000
Net book value
At 31 July 2024 700,000
At 31 July 2023 700,000

ELECTRA PRESCRIBING SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

4. Tangible Assets

Total
Cost £
At 01 August 2023 132,690
Additions 271,645
At 31 July 2024 404,335
Depreciation
At 01 August 2023 49,290
Charge for year 37,381
At 31 July 2024 86,671
Net book value
At 31 July 2024 317,664
At 31 July 2023 83,400